✦ LIBER ✦

Late phase II trials of topotecan (T) for relapsed small cell lung cancer (SCLC)

✍ Scribed by Y. Nishiwaki; S. Negoro; K. Watanabe; M. Fukuoka; H. Niitani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of topotecan (TOP) for re

✍ Ogawara, M; Negoro, S; Nishiwaki, Y; Fukuoka, M; Watanabe, K; Niitani, H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

222 Phase II trial of topotecan for smal

✍ Watanabe, K.; Fukuoka, M.; Niitani, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB

126 Evaluation of topotecan (Hycamtin™)

✍ Depierre, A.; von Pawel, J.; Hans, K.; Moro, D.; Clark, P.; Gatzemeier, U.; Pail 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Efficacy of reduced dose of IV topotecan

✍ Fields, S.Z; Eckardt, J.R; Zhang, L; Poulin, R.K; Rose, G; Schiller, J.H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A phase I clinical trial of weekly oral

✍ S. Agelaki, E. Kontopodis, A. Kotsakis… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 192 KB

P-558 Phase-II trial of topotecan and et

✍ Reck, Martin; Buchholz, Erika; Groth, Gesine; Kaubitzsch, Sabine; Gatzemeier, Ul 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB